ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement

被引：0
|
作者：
Ikenaga, Naoki [1 ]
Miyasaka, Yoshihiro [2 ]
Ohtsuka, Takao [3 ]
Nakamura, Masafumi [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan
[2] Fukuoka Univ, Chikushi Hosp, Dept Surg, Chikushino, Japan
[3] Kagoshima Univ, Grad Sch Med Sci, Digest Surg Breast & Thyroid Surg, Kagoshima, Japan
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / 01期
关键词：
D O I：
10.1245/s10434-022-12584-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：203 / 204
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer
    Kharofa, Jordan
    Tsai, Susan
    Kelly, Tracy
    Wood, Clint
    George, Ben
    Ritch, Paul
    Wiebe, Lauren
    Christians, Kathleen
    Evans, Douglas B.
    Erickson, Beth
    RADIOTHERAPY AND ONCOLOGY, 2014, 113 (01) : 41 - 46
  • [42] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Ammar A. Javed
    Michael J. Wright
    Ayat Siddique
    Alex B. Blair
    Ding Ding
    Richard A. Burkhart
    Martin Makary
    John L. Cameron
    Amol Narang
    Joseph Herman
    Lei Zheng
    Daniel Laheru
    Matthew J. Weiss
    Christopher Wolfgang
    Jin He
    Journal of Gastrointestinal Surgery, 2019, 23 : 112 - 121
  • [43] Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer
    Hashimoto, D.
    Satoi, S.
    Yamamoto, T.
    Yamaki, S.
    Hirooka, S.
    Ishida, M.
    Ikeura, T.
    Sekimoto, M.
    PANCREAS, 2021, 50 (07) : 1064 - 1064
  • [44] Neoadjuvant therapy in borderline resectable and resectable pancreatic cancer.
    Dhamija, Kriti
    Awuah, Kojo-Frimpong B.
    Marwaha, Alexander
    Kharoud, Harmeet
    Monga, Dulabh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 735 - 735
  • [45] OUTCOME OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER IN THE CONTEMPORARY ERA OF NEOADJUVANT CHEMOTHERAPY
    Javed, Ammar A.
    Siddique, Ayat
    Blair, Alex
    Parish, Lindsay
    Burkhart, Richard
    Weiss, Matthew J.
    Cameron, John
    Narang, Amol
    Zheng, Lei
    Laheru, Daniel
    Wolfgang, Christopher L.
    He, Jin
    GASTROENTEROLOGY, 2018, 154 (06) : S1265 - S1265
  • [46] ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
    Roberto Alva-Ruiz
    Mark J. Truty
    Annals of Surgical Oncology, 2022, 29 : 1592 - 1593
  • [47] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Janssen, Quisette P.
    O'Reilly, Eileen M.
    Van Eijck, Casper H. J.
    Groot Koerkamp, Bas
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    CHIRURG, 2020, 91 (05): : 391 - 395
  • [50] ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
    Alva-Ruiz, Roberto
    Truty, Mark J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1592 - 1593
12345